Chemotherapy for advanced gastric cancer-Reference-Cited by-同舟云学术

Chemotherapy for advanced gastric cancer

Published:2017-08-29 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Wagner Anna Dorothea¹,Syn Nicholas LX²,Moehler Markus³,Grothe Wilfried⁴,Yong Wei Peng²,Tai Bee-Choo⁵,Ho Jingshan²,Unverzagt Susanne⁶

Affiliation:

1. Lausanne University Hospitals and Clinics; Department of Oncology; Rue du Bugnon 46 Lausanne Switzerland 1011

2. National University Cancer Institute; Department of Haematology-Oncology; 1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore Singapore 119228

3. University Medical Center of the Johannes Gutenberg University; Department of Internal Medicine; Langenbeckstrasse 1 Mainz Germany 55131

4. Martin-Luther-University Halle-Wittenberg; Department of Internal Medicine I; Ernst-Grube-Str. 40 Halle/Saale Germany 06097

5. National University of Singapore; Saw Swee Hock School of Public Health; 12 Science Drive 2 #10-03F Singapore Singapore 117549

6. Martin-Luther-University Halle-Wittenberg; Institute of Medical Epidemiology, Biostatistics and Informatics; Magdeburge Straße 8 Halle/Saale Germany 06097

Publisher

Wiley

Subject

Pharmacology (medical)

Reference389 articles.

1. Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma;Ajani;Journal of Clinical Oncology,2005

2. Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study;Ajani;European Journal of Cancer,2013

3. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial;Ajani;Journal of Clinical Oncology,2010

4. Bodoky G Carrato A Ravaioli A Ajani JA Quality of life in flags trial a randomized, comparative, open label, multicenter, phase 3 of S-1 + cisplatin (CS) compared to 5-fu + cisplatin (CF) in untreated advanced gastric cancer (AGC) patients Annals of Oncology 2012 ix232 ix233

5. Clinical benefit and health-related quality of life assessment in patients treated with cisplatin/S-1 versus cisplatin/5-FU: secondary end point results from the First-Line Advanced Gastric Cancer Study (FLAGS);Bodoky;Journal of Gastrointestinal Cancer,2015

Cited by 312 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial;Gastric Cancer;2024-02-03

2. Antibody-mediated targeting of Claudins in cancer;Frontiers in Oncology;2024-02-02

3. Identification and characterization of CLEC11A and its derived immune signature in gastric cancer;Frontiers in Immunology;2024-01-29

4. A bispecific antibody targeting HER2 and CLDN18.2 eliminates gastric cancer cells expressing dual antigens by enhancing the immune effector function;Investigational New Drugs;2024-01-10

5. Transcription Analysis of the THBS2 Gene through Regulation by Potential Noncoding Diagnostic Biomarkers and Oncogenes of Gastric Cancer in the ECM-Receptor Interaction Signaling Pathway: Integrated System Biology and Experimental Investigation;International Journal of Genomics;2023-12-22